Antipsychotic Drugs Market
- 2026 年市場規模
- USD 19.4 Bn
- 2033 年預估規模
- USD 32.24 Bn
- 年複合成長率 CAGR
- 7.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Antipsychotic Drugs Market, By Disease (Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Others), By Drug (Risperidone, Quetiapine, Olanzapine, Aripiprazole, Brexpiprazole, Paliperidone Palmitate, Others), By Therapeutic Class (First Generation, Second Generation, Third Generation),By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
The Antipsychotic Drugs Market is estimated to be valued at USD 19.4 Bn in 2026 and is expected to reach USD 32.24 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 7.5% from 2026 to 2033. The market is experiencing steady expansion driven by the rising global burden of mental health disorders such as schizophrenia, bipolar disorder, and psychosis, alongside increasing awareness, diagnosis rates, and acceptance of long-term pharmacological treatment strategies.
Antipsychotic drugs play a critical role in managing severe psychiatric conditions by regulating neurotransmitter activity, particularly dopamine and serotonin pathways, to control symptoms such as hallucinations, delusions, and mood instability. The market includes both first-generation (typical) and second- and third-generation (atypical) antipsychotics, with atypical drugs increasingly preferred due to improved efficacy and reduced side-effect profiles.
Technological advancements in drug development, particularly long-acting injectable (LAI) formulations and novel atypical molecules, are transforming treatment outcomes by improving patient adherence and reducing relapse rates. Additionally, growing regulatory support for innovative therapies and increasing focus on personalized psychiatric care are further strengthening market growth prospects across global regions.
Market Dynamics
The Antipsychotic Drugs Market is witnessing robust growth due to multiple converging clinical, demographic, and regulatory factors. A key driver is the increasing prevalence of mental health disorders worldwide. Schizophrenia alone affects over 20 million people globally, while bipolar disorder and related psychotic conditions continue to contribute significantly to long-term disability, creating sustained demand for antipsychotic therapies.
Another major growth factor is the rising geriatric population, which is more susceptible to dementia-related psychosis and other neuropsychiatric conditions requiring antipsychotic intervention. Expanding awareness and reduced stigma around mental health treatment are also contributing to higher diagnosis and treatment rates, especially in emerging economies.
The market is further supported by continuous innovation in drug formulations. Long-acting injectable antipsychotics are gaining strong adoption due to improved medication adherence and reduced hospitalization rates. Additionally, the introduction of newer atypical antipsychotics and extended-release formulations is enhancing treatment outcomes and expanding therapeutic options for clinicians.
However, challenges such as adverse side effects, patient non-adherence, and reimbursement limitations for newer therapies continue to restrain market growth to some extent. Despite these challenges, increasing healthcare expenditure, expansion of mental health programs, and strong regulatory pipelines are expected to sustain long-term market expansion.
Key Features of the Study
• This report provides in-depth analysis of the Antipsychotic Drugs Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the Antipsychotic Drugs Marketbased on the following parameters – company highlights, service portfolio, key developments, financial performance, and strategies
• Key companies covered as a part of this study include H. Lundbeck A/S; Otsuka Pharmaceutical Co., Ltd.; Janssen Pharmaceuticals, Inc.; Eli Lilly and Company; AbbVie, Inc.; Teva Pharmaceutical Industries Ltd.; Dr. Reddy’s Laboratories Ltd.; Sumitomo Pharma Co., Ltd.; Alkermes; Bristol-Myers Squibb Company
• Insights from this report would allow marketers and management authorities to make informed decisions regarding future service innovations, market expansion, and strategic partnerships
• The Antipsychotic Drugs Market report caters to various stakeholders including investors, service providers, pharmaceutical companies, regulatory bodies, and financial analysts
• Stakeholders would benefit from structured analytical frameworks and strategy matrices used in evaluating the Antipsychotic Drugs Market
Market Segmentation
• By Disease (Revenue, USD Bn, 2026-2033)
o Schizophrenia
o Bipolar Disorder
o Unipolar Depression
o Dementia
o Others
• By Drug (Revenue, USD Bn, 2026-2033)
o Risperidone
o Quetiapine
o Olanzapine
o Aripiprazole
o Brexpiprazole
o Paliperidone Palmitate
o Others
• By Therapeutic Class (Revenue, USD Bn, 2026-2033)
o First Generation
o Second Generation
o Third Generation
• By Distribution Channel (Revenue, USD Bn, 2026-2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region (Revenue, USD Bn, 2026-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Company Profiles
o Lundbeck A/S
o Otsuka Pharmaceutical Co., Ltd.
o Janssen Pharmaceuticals, Inc.
o Eli Lilly and Company
o AbbVie, Inc.
o Teva Pharmaceutical Industries Ltd.
o Reddy’s Laboratories Ltd.
o Sumitomo Pharma Co., Ltd.
o Alkermes
o Bristol-Myers Squibb Company
目錄 Table of Contents
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Disease
Market Snippet, By Drug
Market Snippet, By Therapeutic Class
Market Snippet, By Distribution Channel
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Key Developments
o Technological Advancement
o Regulatory Scenario
4. Global Antipsychotic Drugs Market, By Disease, 2021– 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Schizophrenia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Bipolar Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Unipolar Depression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Dementia
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
5. Global Antipsychotic Drugs Market, By Drug, 2021 – 2033 (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Risperidone
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Quetiapine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Olanzapine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Aripiprazole
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Brexpiprazole
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Paliperidone Palmitate
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
6. Global Antipsychotic Drugs Market, By Therapeutic Class 2021– 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o First Generation
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Second Generation
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Third Generation
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
7. Global Antipsychotic Drugs Market, By Distribution Channel 2021– 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size, Volume and Forecast, and Y-o-Y Growth, 2021 – 2033, (USD Bn)
8. Global Antipsychotic Drugs Market, By Region, 2021– 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of APAC
o Middle East
Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Market Size and Forecast, By Disease, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Drug, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Therapeutic Class, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Distribution Channel, 2021 – 2033, (USD Bn)
Market Size and Forecast, By Country, 2021 – 2033, (USD Bn)
o South Africa
o Central Africa
o North Africa
9. Competitive Landscape
o Company Profiles
H. Lundbeck A/S
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Otsuka Pharmaceutical Co., Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Janssen Pharmaceuticals, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
AbbVie, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Teva Pharmaceutical Industries Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Dr. Reddy’s Laboratories Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Sumitomo Pharma Co., Ltd.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Alkermes
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Bristol-Myers Squibb Company
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
10. Section
o References
o Research Methodology
o About us and Sales Contact
*Browse 24 market data tables and 20 figures on “Antipsychotic Drugs – Global forecast to 2033.
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們